Lenvatinib Mesylate and Paraplatin NovaPlus
Determining the interaction of Lenvatinib Mesylate and Paraplatin NovaPlus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Parathyroid hormone
- Lenvatinib Mesylate-Parathyroid hormone Subcutaneous
- Lenvatinib Mesylate-Parcopa
- Lenvatinib Mesylate-Paregoric
- Lenvatinib Mesylate-Paremyd
- Lenvatinib Mesylate-Paremyd Ophthalmic
- Paraplatin NovaPlus-Lenvima
- Paraplatin NovaPlus-Lenvima (14 MG Daily Dose)
- Paraplatin NovaPlus-Lenvima (18 MG Daily Dose)
- Paraplatin NovaPlus-Lenvima (20 MG Daily Dose)
- Paraplatin NovaPlus-Lenvima (24 MG Daily Dose)
- Paraplatin NovaPlus-Lenvima (8 MG Daily Dose)